- Home
- BANL vs CASI Comparison
BANL vs CASI Comparison
Compare BANL & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANL
- CASI
- Stock Information
- Founded
- BANL 2015
- CASI 1991
- Country
- BANL Malaysia
- CASI China
- Employees
- BANL N/A
- CASI N/A
- Industry
- BANL Oil Refining/Marketing
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- BANL Energy
- CASI Health Care
- Exchange
- BANL Nasdaq
- CASI Nasdaq
- Market Cap
- BANL 25.3M
- CASI 20.5M
- IPO Year
- BANL 2023
- CASI 1996
- Fundamental
- Price
- BANL $0.69
- CASI $1.73
- Analyst Decision
- BANL
- CASI Strong Buy
- Analyst Count
- BANL 0
- CASI 1
- Target Price
- BANL N/A
- CASI $4.00
- AVG Volume (30 Days)
- BANL 133.3K
- CASI 3.4M
- Earning Date
- BANL 09-11-2025
- CASI 08-19-2025
- Dividend Yield
- BANL N/A
- CASI N/A
- EPS Growth
- BANL N/A
- CASI N/A
- EPS
- BANL N/A
- CASI N/A
- Revenue
- BANL $592,517,545.00
- CASI $31,368,000.00
- Revenue This Year
- BANL N/A
- CASI N/A
- Revenue Next Year
- BANL N/A
- CASI N/A
- P/E Ratio
- BANL N/A
- CASI N/A
- Revenue Growth
- BANL 35.93
- CASI 8.39
- 52 Week Low
- BANL $0.55
- CASI $1.09
- 52 Week High
- BANL $1.35
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- BANL 38.42
- CASI 56.44
- Support Level
- BANL $0.69
- CASI $1.46
- Resistance Level
- BANL $0.75
- CASI $2.57
- Average True Range (ATR)
- BANL 0.05
- CASI 0.27
- MACD
- BANL -0.00
- CASI 0.03
- Stochastic Oscillator
- BANL 18.58
- CASI 36.84
About BANL CBL International Limited
CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.